Sequana Medical is set to launch the Automated Low-Flow Ascites (ALFA) Pump System in Europe.
The ALFA Pump System is a subcutaneously implanted battery-powered pump system that removes excess abdominal fluid, known as ascites, by transferring it to the bladder where it is eliminated through normal urination.
Sequana Medical Commercial Operations vice president Dan Rose said they believe the ALFA Pump System offers patients the relief of fewer repeat interventions and better quality of life while saving money and resources.
Sequana Medical CEO Noel Johnson said they felt the name ‘NovaShunt’ was not well aligned with their current technology or vision for the future.
"Now is an ideal time to transition to a new company name, having just completed a $25m Series B financing round and as we prepare for our first product launch," Johnson said .
